The percentage of Tregs among the CD4+ T cells and MDSCs among CD45+ leukocytes in GC tissue from cancer patients was median 12.7% (range 1.7–37.6%) and median 2.8% (range 0.6–13.6%), respectively. This evidence concerns the gene PTPRC and cancer.